ESView 3.0
Advanced video capsule analysis software with AI-driven reporting
Company profile
Company profile
AnX Robotics, headquartered in Plano, Texas, is at the forefront of robotic capsule innovation, advancing how gastrointestinal diseases are diagnosed and managed through precision-engineered, non-invasive technologies. The company's history is rooted in innovation, with founders who began developing robotic capsule endoscopy technologies in Silicon Valley in 2008, leading to the creation of ANKON Medical Technologies in 2009—the first company in the world to commercialize a magnetically controlled capsule endoscope system. In 2019, AnX Robotics established a commercial partnership with ANKON, bringing this breakthrough technology to the U.S. market and expanding development of a complete suite of GI diagnostic tools. Leveraging in-house expertise in magnetic control, ASIC development, artificial intelligence, micro-optical imaging, and wireless transmission, AnX Robotics is transforming capsule endoscopy into a smarter, more accessible diagnostic experience. The company's product portfolio includes the NaviCam SB with ProScan—the first FDA-cleared AI-assisted capsule reading solution for small bowel video capsule endoscopy—along with NaviCam Capsule/Tether for real-time esophageal visualization without sedation, MotiliCap for whole-gut transit monitoring, and IntraMarX radiopaque colonic markers. The company serves gastroenterologists, health systems, and GI specialty clinics with advanced diagnostic solutions that eliminate the need for sedation, reduce procedure time, and improve patient comfort while maintaining diagnostic accuracy.
Company description Ankon Technologies co., ltd official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · Other deployment with recorded integration context.
Company milestones
Introduction of NaviCam XS (44% smaller capsule by volume), launch of MotiliCap as SmartPill replacement (pending FDA clearance), development of NaviCam XST tethered capsule variant
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Advanced video capsule analysis software with AI-driven reporting
Radiopaque colonic markers for accurate colonic transit assessment
Wireless whole-gut transit monitoring capsule measuring pH, pressure and temperature
Companion software platform for MotiliCap with real-time visualization and analytics
Next-generation smaller capsule, 44% smaller by volume with same image quality
Smaller, more comfortable tethered capsule for esophageal visualization
Advanced capsule technology offering complete, non-invasive view of the colon
First FDA-cleared AI-assisted capsule reading solution for small bowel video capsule endoscopy
Real-time, non-sedated esophageal visualization with tethered capsule
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
NCT05308511 · Mentioned · COMPLETED
Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent ImplantationNCT03198741 · Sponsor · COMPLETED
Regulatory
DEN230027 · De Novo · Dec 12, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Ankon Technologies co., ltd's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.